No more tears: The dark secrets of Johnson & Johnson

ON THIS PAGE

One day in 2004, Gardiner Harris, early for a flight, sat down at an airport bar and started talking to the woman on the barstool beside him. She was a drug sales rep for Johnson & Johnson, and her horrific story about unethical sales practices and the devastating impact they’d had on her family fundamentally changed the nature of how Harris covered the company—and the entire pharmaceutical industry—for The New York Times. His subsequent investigations and ongoing research since that very first conversation led to new federal laws and ultimately to this book, a blistering exposé of a trusted American institution and the largest healthcare conglomerate in the world.

Harris takes us light years away from the company’s image as the child-friendly “baby company” as he uncovers reams of evidence showing decades of deceitful and dangerous corporate practices that have threatened the lives of millions. He covers multiple disasters: lies and cover-ups regarding baby powder’s linkage to cancer, the surprising dangers of Tylenol, a criminal campaign to sell antipsychotics in ways that have cost countless lives, a popular drug used to support cancer patients that actually increases the risk that cancer tumors will grow, and deceptive marketing efforts that accelerated opioid addictions through their product Duragesic (fentanyl) that rival even those of the Sacklers and Purdue Pharma.Filled with shocking, infuriating, but utterly necessary revelations, No More Tears is a landmark work of investigative journalism that lays bare the deeply rooted corruption behind the image of babies bathing with a smile.

Thank you for subscribing. Leave a comment or share this episode.

Make sense of what's next.

A clear-eyed digest of AI, products, and ideas worth understanding. Join the NextBigWhat newsletter.

Free. Unsubscribe anytime.

more AI news

Disney eyes acquisition of Character.ai amid bankruptcy filing

Disney is considering a potential acquisition of Character.ai, a tech startup that has recently filed for Chapter 11 bankruptcy. The move could allow Disney to integrate advanced AI chatbot technology into its offerings. This acquisition could reshape Disney’s approach to digital interactions and character engagement.

Only 5000 people have fully grasped AI’s potential: Andrej Karpathy

Andrej Karpathy emphasizes that only a small fraction of people, around 5,000, have fully grasped the potential of AI, indicating a growing gap in AI capabilities. Meanwhile, Box CEO Aaron Levie predicts the future of agent swarms in AI, though he notes that most enterprises are currently unprepared to implement such advanced technologies. This highlights the need for increased awareness and readiness among businesses to leverage AI effectively.

Meta AI launches Muse Wonder, advancing personal and professional agent capabilities

Meta AI Research has introduced Muse Wonder, a new frontier model designed for enhancing personal and professional agent functionalities. This innovative model features a Responsive Step and Repeat hero animation, showcasing its advanced capabilities. The development is set to influence how users interact with AI, potentially transforming productivity and user experience.

Google launches synth-id to identify AI-generated content

Google has introduced a standalone platform called SynthID Detector, designed to help users determine if online content was generated using Google AI or its partner tools. This initiative aims to enhance transparency and trust in digital content, amidst growing concerns about the authenticity of AI-generated materials. The tool reflects Google’s commitment to ethical AI usage and the accountability of content creators.

US halts green card access for major IT firms amid H-1B abuse claims

The US Department of Labor has suspended major tech companies, including Microsoft, Infosys, and Cognizant, from the green card program due to allegations of H-1B visa abuse. This decision impacts several prominent IT firms such as TCS, Wipro, and Capgemini, potentially affecting their ability to recruit foreign talent. The move underscores increasing scrutiny on visa practices within the tech industry.